A radiation device placed inside the tumor for glioblastoma that has come back
Official title: Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is testing a small device that gives off radiation from inside a brain tumor that has returned.
Read our full plain-language summary
What the trial team says
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of recurrent Glioblastoma
Key facts
- Registry number
- NCT06910306
- Stage of testing
- Not applicable
- Conditions studied
- Recurrent Glioblastoma, Recurrent Gliomas
Where it is running
This trial lists 3 sites.
-
Arizona
- Honor Health (Scottsdale)
-
New York
- NYU Langone Health (New York)
-
Ohio
- Ohio State University Medical Center (Columbus)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.